Offered by: Nemours Children's
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Pediatric Previously Untreated Patients With Hemophilia A (GUARDIAN 4)
Study of children with severe hemophilia A.
Male patients age 0-6 years.
The trial includes five planned visits to the clinic which will last approximately one hour. Additional visits may occur if required. It is expected that the entire trial will run for approximately 4 years. Tests include:
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.